Welcome to our dedicated page for Equifax SEC filings (Ticker: EFX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Equifax Inc. (NYSE: EFX) is a global data, analytics, and technology company whose SEC filings provide detailed insight into its credit reporting, workforce solutions, and compliance businesses. Through its periodic reports and current reports, Equifax discloses information about its financial condition, results of operations, risk factors, and significant corporate events.
On this page, you can review Equifax’s U.S. Securities and Exchange Commission filings, including annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe its data, analytics, and cloud technology strategy, global operations across 24 countries, and the performance of areas such as consumer credit information and workforce solutions. Current reports on Form 8-K, such as those filed to announce quarterly financial results, provide timely updates on material events affecting the company.
Investors and analysts can also use this page to access other key documents, including proxy materials related to governance and executive compensation and, where applicable, insider transaction reports on Form 4 that show purchases and sales of Equifax securities by directors and officers. These filings help explain how Equifax manages its role as one of the major U.S. credit bureaus and as a provider of employment verification, AML compliance, and cloud-based analytics solutions.
Stock Titan enhances these filings with AI-powered summaries that highlight important sections and clarify complex disclosures. Real-time updates from the SEC’s EDGAR system ensure that new Equifax filings, including 10-Ks, 10-Qs, 8-Ks, and Forms 3 and 4, are available quickly, while AI-generated insights help readers understand the implications of changes in strategy, risk disclosures, and capital allocation for EFX shareholders.
Equifax Inc. CEO and director Mark W. Begor reported multiple equity transactions dated 02/10/2026. He exercised a stock option for 37,791 shares of common stock at an exercise price of $112.46 per share and received a separate grant of 33,278 common shares at $0.0000.
On the same day, he executed a series of open-market sales of common stock at weighted average prices ranging from $192.8855 to $203.0792 per share, including blocks such as 11,000 and 18,352 shares. A further 1,759 shares were withheld at $202.71 to cover tax obligations.
After these transactions, Begor directly held 230,506 common shares and maintained additional indirect holdings through several GRAT vehicles, including 10,500, 21,284, 22,045, 12,333, and 16,287 shares. The sales were carried out under a Rule 10b5-1 trading plan adopted on 10/28/2025.
Equifax Inc. executive Jamil Farshchi, EVP and Chief Technology Officer, reported multiple stock transactions. On 02/10/2026 he exercised a stock option for 6,213 shares of common stock at $191.44 per share and received an additional 4,667 common shares as a grant at $0.0000 per share. To cover obligations, 3,042 shares were withheld at $202.71 per share. On 02/10/2026 he sold 6,213 common shares at $195.81 per share, and on 02/11/2026 he sold 1,167 common shares at $199.87 per share. The sales were made under a Rule 10b5-1 trading plan adopted on 4/25/2025, and he held 39,869 common shares directly after the reported transactions.
A shareholder filed a notice of proposed sale of 2,535 common shares, with an aggregate market value of 485,452.50. The shares are planned to be sold on or about 02/12/2026 on the NYSE through Fidelity Brokerage Services LLC.
These shares were acquired on 05/06/2025 via restricted stock vesting from the issuer as compensation, with the same date listed as the payment date. The filing notes total shares outstanding of 122,394,037 for the same class of common stock.
Equifax insider Jamil Farshchi has filed a notice to sell company stock. The filing covers a planned sale of 1,167 shares of common stock on the NYSE through Fidelity Brokerage Services, with an approximate sale date of 02/11/2026 and an aggregate market value of 233,248.29.
The 1,167 shares were acquired on 02/10/2026 through restricted stock vesting as compensation from the issuer. The notice also shows that on 02/10/2026, Farshchi sold 6,213 common shares for gross proceeds of 1,216,567.53.
A person has filed a notice of proposed sale of 6,213 shares of common stock through Fidelity Brokerage Services LLC on the NYSE. The planned sale date is February 10, 2026, with an indicated aggregate market value of $1,216,567.53.
The securities were acquired on February 10, 2026 through an option that was originally granted on February 21, 2020, and the exercise price was paid in cash on the same acquisition date. The filing indicates total 122,394,037 shares of this class of common stock are outstanding.
A shareholder has filed a notice of intent to sell 37,791 shares of common stock through Fidelity Brokerage Services LLC, to be sold on the NYSE around
The shares were acquired as a stock option granted on
Equifax Inc. CEO and director Mark W. Begor reported equity transactions in company common stock dated February 3, 2026. He acquired 59,123 shares of common stock at $0.0000 per share and had 2,405 shares disposed of at $175.05 per share, leaving 198,987 shares directly owned.
The filing also lists indirect holdings in several grantor retained annuity trusts (GRATs), including 10,500, 21,284, 22,045, 12,333 and 16,287 shares of common stock. A footnote explains that the reported direct holdings include accrued dividend equivalent units and 199 shares purchased under the Equifax Inc. 2020 Employee Stock Purchase Plan.
Equifax Inc. filed a current report to note that it has released its financial results for the three- and twelve-month periods ended December 31, 2025. The company issued a press release on February 4, 2026, and attached the full text as an exhibit to this report.
The press release, included as Exhibit 99.1, is designated as “furnished” rather than “filed” under securities law, which affects how it is treated for certain liability and incorporation-by-reference purposes. No specific revenue, profit, or other financial figures are detailed in this report itself.
Equifax Inc. CEO and director Form 4 filing details insider share activity. On 12/31/2025, a reporting person had 997 shares of Equifax common stock withheld in a transaction coded "F" at a price of $216.98 per share, typically indicating shares withheld to cover taxes on equity awards. After this transaction, the insider directly beneficially owned 142,091 shares of common stock. The insider also held additional indirect interests through several grantor retained annuity trusts (GRATs), including 10,500 shares in a 2-year 2025 GRAT, 21,284 shares in a 2-year December 2025 GRAT, 22,045 shares in a 2-year June 2025 GRAT, 12,333 shares in a 2-year May 2025 GRAT, and 16,287 shares in a 3-year July 2024 GRAT. The holdings include accrued dividend equivalent units and 199 shares purchased under the Equifax Inc. 2020 Employee Stock Purchase Plan.
Equifax Inc. director reports additional deferred stock-based compensation. A board member of Equifax Inc. (EFX), filing as a director and sole reporting person, recorded an acquisition of 156 phantom stock units on 12/31/2025 under the company’s Board of Directors Deferred Compensation Plan. Each phantom stock unit is the economic equivalent of one share of Equifax common stock and represents fees that the director elected to receive in stock-based form instead of cash annual retainer payments. After this transaction, the director beneficially owns 2,284 phantom stock units held directly. These units are payable, at the director’s election, upon termination of service as a director, meaning the value tracks Equifax’s stock until that time but does not involve immediate cash or share delivery.
FAQ
What is the current stock price of Equifax (EFX)?
What is the market cap of Equifax (EFX)?
